< Back to previous page

Publication

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

Journal Contribution - Journal Article

Journal: Alimentary Pharmacology & Therapeutics

ISSN: 0269-2813

Issue: 1

Volume: 51

Pages: 129 - 138

Publication year:2020

DOI: https://doi.org/10.1111/apt.15539
Institutional Repository URL: https://lirias.kuleuven.be/3518478

See also: Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
See also: Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy